190 related articles for article (PubMed ID: 27792416)
1. Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal rule.
Longstreth J; Skiadopoulos MH; Hopkins RJ
Expert Rev Vaccines; 2016 Dec; 15(12):1467-1479. PubMed ID: 27792416
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in the understanding and use of anthrax vaccine adsorbed: achieving more with less.
Schiffer JM; McNeil MM; Quinn CP
Expert Rev Vaccines; 2016 Sep; 15(9):1151-62. PubMed ID: 26942655
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.
Sivko GS; Stark GV; Tordoff KP; Taylor KL; Glaze E; VanRaden M; Schiffer JM; Hewitt JA; Quinn CP; Nuzum EO
Vaccine; 2016 Dec; 34(51):6518-6528. PubMed ID: 27155494
[TBL] [Abstract][Full Text] [Related]
4. Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparing.
Stark GV; Sivko GS; VanRaden M; Schiffer J; Taylor KL; Hewitt JA; Quinn CP; Nuzum EO
Vaccine; 2016 Dec; 34(51):6512-6517. PubMed ID: 27558619
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults.
Hopkins RJ; Kalsi G; Montalvo-Lugo VM; Sharma M; Wu Y; Muse DD; Sheldon EA; Hampel FC; Lemiale L
Vaccine; 2016 Apr; 34(18):2096-105. PubMed ID: 26979136
[TBL] [Abstract][Full Text] [Related]
6. Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans.
Schiffer JM; Chen L; Dalton S; Niemuth NA; Sabourin CL; Quinn CP
Vaccine; 2015 Jul; 33(31):3709-16. PubMed ID: 26072016
[TBL] [Abstract][Full Text] [Related]
7. Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
Wright JG; Quinn CP; Shadomy S; Messonnier N;
MMWR Recomm Rep; 2010 Jul; 59(RR-6):1-30. PubMed ID: 20651644
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis.
Ionin B; Hopkins RJ; Pleune B; Sivko GS; Reid FM; Clement KH; Rudge TL; Stark GV; Innes A; Sari S; Guina T; Howard C; Smith J; Swoboda ML; Vert-Wong E; Johnson V; Nabors GS; Skiadopoulos MH
Clin Vaccine Immunol; 2013 Jul; 20(7):1016-26. PubMed ID: 23658392
[TBL] [Abstract][Full Text] [Related]
9. Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019.
Bower WA; Schiffer J; Atmar RL; Keitel WA; Friedlander AM; Liu L; Yu Y; Stephens DS; Quinn CP; Hendricks K;
MMWR Recomm Rep; 2019 Dec; 68(4):1-14. PubMed ID: 31834290
[TBL] [Abstract][Full Text] [Related]
10. Phase 3 trial evaluating the immunogenicity and safety of a three-dose BioThrax® regimen for post-exposure prophylaxis in healthy adults.
Hopkins RJ; Howard C; Hunter-Stitt E; Kaptur PE; Pleune B; Muse D; Sheldon E; Davis M; Strout C; Vert-Wong K
Vaccine; 2014 Apr; 32(19):2217-24. PubMed ID: 24613523
[TBL] [Abstract][Full Text] [Related]
11. Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.
Wright JG; Plikaytis BD; Rose CE; Parker SD; Babcock J; Keitel W; El Sahly H; Poland GA; Jacobson RM; Keyserling HL; Semenova VA; Li H; Schiffer J; Dababneh H; Martin SK; Martin SW; Marano N; Messonnier NE; Quinn CP
Vaccine; 2014 Feb; 32(8):1019-28. PubMed ID: 24373307
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis against anthrax.
Splino M; Patocka J
Acta Medica (Hradec Kralove); 2002; 45(3):85-8. PubMed ID: 12515043
[TBL] [Abstract][Full Text] [Related]
13. Correlation between anthrax lethal toxin neutralizing antibody levels and survival in guinea pigs and nonhuman primates vaccinated with the AV7909 anthrax vaccine candidate.
Savransky V; Shearer JD; Gainey MR; Sanford DC; Sivko GS; Stark GV; Li N; Ionin B; Lacy MJ; Skiadopoulos MH
Vaccine; 2017 Sep; 35(37):4952-4959. PubMed ID: 28774566
[TBL] [Abstract][Full Text] [Related]
14. Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults.
Campbell JD; Clement KH; Wasserman SS; Donegan S; Chrisley L; Kotloff KL
Hum Vaccin; 2007; 3(5):205-11. PubMed ID: 17881903
[TBL] [Abstract][Full Text] [Related]
15. Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers.
Rynkiewicz D; Rathkopf M; Sim I; Waytes AT; Hopkins RJ; Giri L; DeMuria D; Ransom J; Quinn J; Nabors GS; Nielsen CJ
Vaccine; 2011 Aug; 29(37):6313-20. PubMed ID: 21624418
[TBL] [Abstract][Full Text] [Related]
16. Results of a safety and immunogenicity study of an early-stage investigational rPA102 vaccine as compared to the FDA licensed anthrax vaccine (anthrax vaccine adsorbed (AVA. BioThrax)).
Hannesschlager JR
Vaccine; 2007 Apr; 25(17):3247. PubMed ID: 17234308
[No Abstract] [Full Text] [Related]
17. Development of a guinea pig inhalational anthrax model for evaluation of post-exposure prophylaxis efficacy of anthrax vaccines.
Perry MR; Ionin B; Barnewall RE; Vassar ML; Reece JJ; Park S; Lemiale L; Skiadopoulos MH; Shearer JD; Savransky V
Vaccine; 2020 Feb; 38(10):2307-2314. PubMed ID: 32029323
[TBL] [Abstract][Full Text] [Related]
18. Gorse GJ, et al. "Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial" [Vaccine 24 (2006) 5950-5959].
Zink TK
Vaccine; 2007 Apr; 25(15):2766-7. PubMed ID: 17224206
[TBL] [Abstract][Full Text] [Related]
19. Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.
Marano N; Plikaytis BD; Martin SW; Rose C; Semenova VA; Martin SK; Freeman AE; Li H; Mulligan MJ; Parker SD; Babcock J; Keitel W; El Sahly H; Poland GA; Jacobson RM; Keyserling HL; Soroka SD; Fox SP; Stamper JL; McNeil MM; Perkins BA; Messonnier N; Quinn CP;
JAMA; 2008 Oct; 300(13):1532-43. PubMed ID: 18827210
[TBL] [Abstract][Full Text] [Related]
20. Anthrax vaccine adsorbed: further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed.
Pittman PR; Cavicchia MA; Kingsbury JL; Johnson NA; Barrera-Oro JG; Schmader T; Korman L; Quinn X; Ranadive M
Vaccine; 2014 Sep; 32(39):5131-9. PubMed ID: 24837771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
